Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

BerGenBio - Disclosure of large shareholding

Oncoinvent
Investinor Direkte AS ("Investinor") has today sold 2,000,000 shares in
BerGenBio ASA ("BerGenBio"). After the transaction, Investinor holds 2,770,780
shares representing approx. 3.13% of the total share capital in BerGenBio.

With reference to the ongoing rights issue in BerGenBio, Investinor has already
subscribed for 175,000,000 new shares in the rights issue corresponding to an
amount of NOK 17,500,000. Furthermore, Investinor has over the last days bought
2,500,000 subscription rights in BerGenBio, increasing the total holding of
subscription rights to 207,517,382.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.